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http://dx.doi.org/10.1016/j.jfma.201Background/Purpose: Kawasaki disease (KD) is a disease of unknown cause. To investigate the
infectious etiology of Kawasaki disease, we initiated a prospective case-control study to inves-
tigate possible links between common viral infections and Kawasaki disease.
Methods: We enrolled 226 children with KD and 226 age- and sex-matched healthy children
from February 2004 to March 2010. Throat and nasopharyngeal swabs were taken for both viral
isolation and polymerase chain reaction (PCR) for various viruses.
Results: The mean age of the 226 KD cases was 2.07 years, and the male to female ratio was
1.43 (133 boys to 93 girls). Their mean fever duration was 7.5 days with a mean peak temper-
ature of 39.7C. In addition to the typical symptoms of fever, neck lymphadenopathy, lip
fissure and/or strawberry tongue, skin rash, nonpurulent bulbar conjunctivitis, palm/sole ery-
thema, and induration followed by periungual desquamation, these KD cases also exhibited
cough (69%), rhinorrhea (58%), and diarrhea (45%). Cases of KD had a significantly higher pos-
itive rate of viral isolation in comparison with the control group (7.5% vs. 2.2%, p Z 0.02).
Compared with the control group, cases of KD were more likely to have overall positive rates
of viral PCR (50.4% vs. 16.4%, p < 0.001) and for various viruses including enterovirus (16.8% vs.
4.4%, p < 0.001), adenovirus (8.0% vs. 1.8%, p Z 0.007), human rhinovirus (26.5% vs. 9.7%,
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Viral infections and Kawasaki disease 149Conclusion: We found that some common respiratory viruses, such as adenoviruses, enterovi-
ruses, rhinoviruses, and coronaviruses, were associated with KD cases.
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Kawasaki disease (KD) is an acute systemic febrile illness of
unknown etiology which predominantly affects children
under 5 years of age. Initially described in 1967 by Tomisaku
Kawasaki,1 it is now the most common cause of acquired
heart diseases in children in the developed world due to the
less frequent occurrence of rheumatic heart disease. There
have been reports of differing incidence rates in different
countries. Asian countries are supposed to have higher in-
cidences of KD (30e200/per 100,000 children under 5 years
of age) than most of the Western countries (3.5e10/per
100,000 children under 5 years of age).2e10
The etiology of KD is still controversial and infections are
considered to be one of the predisposing factors. The in-
fectious evidence of Kawasaki disease includes temporal
clustering and marked seasonality, geographic clustering,
family clustering, a high association between Kawasaki
disease and infectious disease surveillance, and age distri-
bution, for which the highest incidence rates are seen
among 6 monthe2-year-old children who have low maternal
antibodies and are most susceptible to infections in gen-
eral.11e14 We hypothesize that infections with certain vi-
ruses may elicit systemic inflammation, and further small
and median sized vasculitis, so-called Kawasaki disease, in
certain hosts because we found a higher incidence of KD
among males, young children, and Asian populations. We
thus carried out a prospective case-control study to inves-
tigate the association of common viral infections with Ka-
wasaki disease to test the above hypothesis.Patients and methods
Case enrollment
From February 2004 to March 2010, we enrolled patients
who fulfilled the Kawasaki disease criteria at the National
Taiwan University Hospital in Taipei City, Taiwan and other
collaborative hospitals including Taiwan Adventist Hospital
in Taipei City, Far Eastern Memorial Hospital in New Taipei
City, and Min-Sheng Hospital in Tao-Yuan County, Taiwan.
We enrolled Kawasaki disease cases that had fever for
over 5 days and at least four of the following five mani-
festations: neck lymphadenopathy, lip fissure and/or
strawberry tongue, skin rash, nonpurulent bulbar conjunc-
tivitis, palm/sole erythema, and induration followed by
periungual desquamation. The onset of KD illness cases was
defined as the 1st day of fever onset.
After informed consent was obtained from the parents, a
questionnaire-styled interview was carried out to solicit
clinical symptoms and previous contact history with ill
household members or with ill people from outside of the
household. The illness included sore throat, rash, fever,
conjunctivitis, cough, rhinorrhea, abdominal pain, anddiarrhea. Clinical laboratory data and coronary arterial le-
sions were collected from the participants, and all received
intravenous immunoglobulin 2 g per Kg plus low-dose
aspirin (3e5 mg per Kg). If fever persisted for 2 days after
use of intravenous immunoglobulin, retreatment with
intravenous immunoglobulin was administered.
Two-dimensional echocardiography was performed in all
patients during hospitalization and was repeated at
convalescence, 2 weeks, and 8 weeks after discharge.
Coronary arterial lesions were defined as coronary arterial
dilatation/ectasia, aneurysm, and increased echogenecity,
irregularity of vascular wall, or coronary artery aneurysm. A
coronary artery aneurysm was defined as having a lumen
diameter (inner border to inner border) of 3 mm in KD
cases less than 5 years old and 4 mm in cases less than 5
years old, and giant aneurysm was defined as a lumen
diameter of 8 mm for any one echocardiography. We took
nasopharyngeal swabs and throat swabs from KD cases on
the 1st day of hospitalization. These swabs were processed
for both viral isolation and polymerase chain reaction (PCR)
for various viruses.
Enrollment of control participants
For the healthy control group, we enrolled children who
were age- and sex-matched with the KD cases, and who did
not have preceding illness for the 2 weeks prior to enroll-
ment. The preceding illness included sore throat, rash,
fever, conjunctivitis, cough, rhinorrhea, abdominal pain,
and diarrhea. These children were kindergarteners or
children who visited our baby wellness clinics for vaccina-
tion. Informed consent was obtained from parents of all
children in the control group. We also took throat swabs
and nasopharyngeal swabs from the control children for
viral isolation and viral PCR.
Laboratory methods
Virus isolation
Throat or nasopharyngeal swabs were submitted for virus
isolation. Samples were inoculated into human embryonic
fibroblast, LLC-MK2, Hep-2, and rhabdomyosarcoma cell
cultures. When a cytopathic effect involved more than 50%
of the cell monolayer, cells were scraped and subjected to
indirect fluorescent antibody staining with specific anti-
bodies or typed by specific methods according to the sus-
pected types of viruses.
Molecular diagnosis for viruses
RNA and DNA extraction from throat swabs, and nasopha-
ryngeal swabs were performed using MagNA Pure LC 2.0
System and MagNA Pure LC Total Nucleic Acid Isolation Kit
(Roche Applied Science, Roche Diagnostics, Indianapolis,
IN, USA). The primers and probes for enterovirus, adeno-
virus, influenza B, rhinovirus, metapneumovirus real-time
150 L.-Y. Chang et al.PCR, and coronavirus PCR are presented in Table 1. Primers
and probes for pan-enterovirus were selected based on
highly conserved regions in the 50-untranslated region of
the enterovirus genome, and design of primers of other
viruses are also based on their most conserved regions. The
detection limitation of each virus was 100 copies for
enterovirus, 100 for adenovirus, 60 for influenza B virus, 50
for rhinovirus, 50 for metapneumovirus, and 10,000 for
coronavirus.
If the samples had positive viral isolation or PCR, further
molecular typing was done. The detailed method of the
viral molecular typing is in the Supplementary Material
online.
Ethics approval
This study was conducted in Taiwan only and institutional
review board (IRB) approval was obtained from National
Taiwan University Hospital (IRB number 9361700624).Table 1 Primers and probes for pan-enterovirus, pan-
adenovirus, pan-coronavirus, metapneumovirus, rhinovirus,
and influenza B PCR.
Primer or probe Sequence
Pan-enterovirus
Forward primer 50-TCCTCCGGCCCCTGAATG
Reverse primer 50-AATTGTCACCATAAGCAGCCA
PanEV probe
(TaqMan)
6FAM-AACCGACTACTTTGGGTGTC
CGTGTTTCXT–PH
Pan-adenovirus
Forward primer 50-GCCACGGTGGGGTTTCTAAACTT-30
Reverse primer 50-GCCCCAGTGGTCTTACATGCACATC-30
Pan-adenovirus
probe (TaqMan)
6FAM-TGCACCAGACCCGGGCTCAGG
TACTCCGA –TMR
Influenza B
Forward primer 50-AAATACGGTGGATTAAATAAAAGCAA-30
Reverse primer 50-CCAGCAATAGCTCCGAAGAAA-30
Probe (TaqMan) 6FAM-CACCCATATTGGGCAATTTCCTA
TGGC–TMR
Human rhinovirus
Forward primer 50-GACARGGTGTGAAGASYC-30
Reverse primer 50-CAAAGTAGTYGGTCCCRTCC-30
HRV probe
(TaqMan)
6FAM-TCCTCCGGCCCCTGAATGYGGC
TAA-BHQ1
Human metapneumovirus
Forward primer 50-CATCAGGTAATATCCCACAAAATCAG-30
Reverse primer 50-GTGAATATTAAGGCACCTACACATA
ATAARA-30
HMPV probe
(TaqMan)
6FAM-TCAGþCACþCAGAþCACAC–BBQ
Pan-coronavirus RT-PCR
Forward primer 50-ACWCARHTVAAYYTNAARTAYGC-3’
Reverse primer 50-TCRCAYTTDGGRTARTCCCA-3’
Pan-coronavirus
semi-nested PCR
Forward primer 50-ACWCARHTVAAYYTNAARTAYGC-30
Reverse primer 50-CCAVCCRCCRTARAAYTT-30
PCR Z polymerase chain reaction; TaqMan Z Taq polymerase
plus PacMan principle.Written informed consent was obtained from the parents of
all participants.
Statistical analysis
The c2 test was used to compare the rates of viral isolation
and PCR of various viruses between KD cases and the con-
trol children. A p value < 0.05 was considered statistically
significant.
Results
Demographics of KD and control cases
In total, 226 KD cases as well as 226 age- and sex-matched
control children were enrolled. The demographic charac-
teristics of the KD cases and the control children are shown
in Table 2. The mean age of KD cases was 2.07  1.76 years,
the median (range) was 1.57 (0.12e9.43) and the male to
female ratio was 1.43 (133 to 93). Their age distribution is
shown in Figure 1; about 62% were younger than 2 years old.
The demographic characteristics of the control children
were comparable to those of the KD cases.
Clinical manifestations of KD cases
Table 3 shows the clinical manifestations. Their mean (SD)
fever duration was 7.5 (2.4) days with mean peak temper-
ature of 39.7C. For the typical clinical features of KD, rash
was found in 92% of the cases, BCG scar erythema and
induration in 44%, palm and/or sole erythema and indura-
tion in 72%, desquamation in 96% (96% of periungual
desquamation and 24% of peri-anal desquamation) and
bulbar conjunctivitis in 97%, red lip with fissure and/or
strawberry tongue in 95%, and neck lymphadenopathy in
40% of cases. KD cases also had other clinical features
including cough (69%), rhinorrhea (58%), and diarrhea
(45%). During the acute stage, 14 (6.2%) children required
intravenous immunoglobulin retreatment, 116 (51%) pa-
tients had coronary arterial lesions, and 28 (12%) patients
had coronary arterial aneurysm.
For the contact history and the rate of household
transmission, 60.8% of the cases had positive contact his-
tory: 51.7% of cases had contact with ill household mem-
bers and 9.1% had positive contact with extra-familial ill
people 1e10 days prior to their KD illness. In 129 (57%) of
the 226 families, at least one of the other family members
had an illness after the onset of disease in the KD cases.Table 2 Demographic characteristics of KD cases and
control children.
KD cases
(N Z 226)
Control children
(N Z 226)
p
Age (y)
Median (range) 1.57 (0.12e9.43) 1.49 (0.05e6.58) 0.73
Mean (SD) 2.07 (1.76) 2.01 (1.77) 0.72
Sex
Male/Female 133/93 (1.43) 126/100 (1.26) 0.57
KD Z Kawasaki disease.
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Figure 1 Age-specific case number and cumulative per-
centage of cases with Kawasaki disease.
Table 4 Viral isolation between KD cases and control
children.
KD cases
(N Z 226)
Control
children
(N Z 226)
p
Positive viral isolationa 17 (7.5) 5 (2.2) 0.02
Specific virus
Enteroviruses 4 (1.8) 3 (1.3) 0.99
Adenoviruses 7 (3.1) 2 (0.9) 0.19
Influenza A 2 (0.9) 0 (0) 0.48
Para-influenza type 3 3 (1.3) 0 (0) 0.25
Data are presented as n (%).
KD Z Kawasaki disease.
a Herpes simplex virus and cytomegalovirus are considered
latent viruses and not included in positive viral isolation.
Table 5 Viral PCR results between KD cases and control
children.
KD cases
(N Z 226)
Control
children
(N Z 226)
p
Any positive 114 (50.4) 37 (16.4) <0.001
Enterovirus 38 (16.8) 10 (4.4) <0.001
Adenovirus 18 (8.0) 4 (1.8) 0.007
Influenza B 2 (0.9) 0 (0) 0.48
Human rhinovirus 60 (26.5) 22 (9.7) <0.001
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Table 4 shows the results of viral isolation and Table 5
shows the results of viral PCR between the KD cases and
the control participants. KD cases had significantly higher
rates of viral isolation (7.5% vs. 2.2%, p Z 0.02) than the
control children. They also had significantly higher positive
rates of PCR (50.4% vs. 16.4%, p < 0.001) for various viruses
including enteroviruses (16.8% vs. 4.4%, p < 0.001), ade-
noviruses (8.0% vs. 1.8%, pZ 0.007), rhinoviruses (26.5% vs.
9.7%, p < 0.001), and pan-coronaviruses (7.1% vs. 0.9%,
p Z 0.003). The overall results of combined viral isolation
and PCR are shown in Table 6.Table 3 Clinical manifestations of KD cases.
Manifestations KD cases
(N Z 226)
Peak body temperature, mean (SD) C 39.7 (0.6)
Duration of fever, mean (SD) (d) 7.5 (2.4)
Rash 208 (92)
BCG scar erythema and induration 99 (44)
Palm and/or sole erythema and induration 162 (72)
Desquamation 217 (96)
Periungual desquamation 216 (96)
Peri-anal desquamation 55 (24)
Bulbar conjunctivitis 219 (97)
Red lip with fissure and/or strawberry tongue 215 (95)
Neck lymphadenopathy 91 (40)
Others
Cough 157 (69)
Rhinorrhea 130 (58)
Diarrhea 102 (45)
Coronary arterial lesionsa 116 (51)
Coronary arterial aneurysmb 28 (12)
Data are presented as n (%), unless otherwise indicated.
KD Z Kawasaki disease; SD Z standard deviation.
a Coronary arterial lesions were defined as coronary arterial
dilatation/ectasia, aneurysm, increased echogenicity or irreg-
ularity, and coronary artery aneurysm.
b A coronary artery aneurysm was defined as having a lumen
diameter (inner border to inner border) of 3 mm in KD cases
<5 years old and 4 mm in cases 5 years old.
Human
metapneumovirus
5 (2.2) 0 (0) 0.08
Coronavirus 16 (7.1) 2 (0.9) 0.003
Data are presented as n (%).
KD Z Kawasaki disease.As for further typing, only one case of echovirus 6 and
one case of EV71 were identified among the 40 enteroviral-
positive KD cases and the other enterovirus serotyping
failed due to low viral titer. For adenovirus, six cases ofTable 6 Positive rate of either viral isolation or PCR re-
sults between KD cases and control children.a
KD cases
(N Z 226)
Control
children
(N Z 226)
p
Any positive 119 (52.7) 37 (16.4) <0.001
Enterovirus 40 (17.7) 10 (4.4) <0.001
Adenovirus 18 (8.0) 4 (1.8) 0.007
Human rhinovirus 60 (26.5) 22 (9.7) <0.001
Human
metapneumovirus
5 (2.2) 0 (0) 0.08
Coronavirus 16 (7.1) 2 (0.9) 0.003
Influenza A 2 (0.9) 0 (0) 0.48
Influenza B 2 (0.9) 0 (0) 0.48
Para-influenza type 3 3 (1.3) 0 (0) 0.25
Data are presented as n (%).
KD Z Kawasaki disease.
a Herpes simplex virus and cytomegalovirus are considered
latent viruses and not considered as positive.
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2, one case of serotype 1, and one case of serotype 4 were
identified in KD cases, whereas two cases of adenovirus
serotype 2, one case of serotype 3, and one case of sero-
type 1 were identified in the control children. For corona-
virus, 12 cases of human coronavirus NL63, three cases of
human coronavirus 229E, and one case of human corona-
virus OC43 were identified in KD cases whereas two of
human coronavirus 229E were identified in the control
children. For rhinovirus, 36 serotypes were identified and
type C was the most common (7 cases) in the 60 rhinovirus-
positive KD cases whereas 14 serotypes were identified and
the Antwerp RV 98/99 type was the most common (5 cases)
among the 22 rhinovirus-positive control children.
Overall, 119 (52.7%) KD cases had positive viral results by
either viral isolation or PCR. However, KD cases with posi-
tive viral results did not have significantly higher percent-
ages of needing intravenous immunoglobulin retreatment
(4% vs. 8%, pZ 0.18), coronary arterial lesions (53% vs. 50%,
p Z 0.70), or coronary arterial aneurysm (11% vs. 14%,
p Z 0.45) than KD cases without positive viral results.Discussion
This was a prospective study to investigate the association
of common viruses with Kawasaki disease. We found that
cases of KD frequently had a cough (69%), rhinorrhea (58%),
and diarrhea (51%) in addition to the typical symptoms of
KD; several common respiratory viruses were also more
frequently detected in cases of KD than in the control
children. We propose that heterogeneous infectious agents,
such as common viruses found in our study, may trigger
Kawasaki disease in young children with certain genetic
backgrounds or susceptibility.
The leading theory of KD etiology is that a ubiquitous
infectious etiologic agent, that usually results in asymp-
tomatic or mild infection in most people, causes KD in a
small subset of genetically predisposed children. In our
study, approximately 60% of KD cases had a preceding
contact history with people of febrile, respiratory, or
gastrointestinal illness, and KD cases frequently had cough
(69%), rhinorrhea (58%), and diarrhea (45%), which sup-
ported certain kinds of viral infections. A winterespring
predominance of KD cases in non-temperate climates also
suggests the association of KD with some kinds of viral in-
fections,11 particularly a respiratory infection, and this
theory is supported by the two articles which reported a
preceding history of respiratory illness in some KD pa-
tients.7,8 The other infectious evidence of Kawasaki disease
includes geographic clustering, family clustering, high as-
sociation between Kawasaki disease and infectious disease
surveillance, and age distribution, with the highest inci-
dence rates among children aged from 6 months to 2 years
old who have low maternal antibodies and are most sus-
ceptible to infections in general.11e14
Many studies worked on a certain single pathogen to be
associated with KD. Various infectious agents including
bacterial (Staphylococcus aureus, group A Streptococcus,
Yersinia pseudotuberculosis, Klebsiella pneumoniae,
Pseudomonas aeruginosa), viral (parvovirus B19, Eps-
teineBarr virus, CMV, HHV6, retrovirus, rotavirus, para-influenza virus, New Haven coronavirus, measles, chick-
enpox, dengue fever), Chlamydiae pneumoniae, Myco-
plasma pneumoniae, Rickettsial organisms, and so-called
KD agent, a viral etiology characterized by intracytoplasmic
inclusion bodies, have been found to be associated with
KD.15e39 However, at present, links between any of these
individual agents and KD have not been irrefutably
established.
Although KD had temporal clustering, different season-
ality was found in different countries. For example, studies
from Europe and Canada reported a higher incidence
in winter,40 whereas Taiwan and Korea have the highest
incidence rates of KD during the summer,11,41 Beijing and
Hong Kong in the spring and summer, and Japan in January
and summer.3,42,43 Such seasonality and temporal clustering
of KD suggests that different infectious diseases in different
countries might trigger this clustering presentation. In the
summer, enterovirus infection was one of the most common
infections in young children in Taiwan. We also detected
enterovirus most frequently in KD cases, which links
enterovirus with KD in the summer. Other respiratory vi-
ruses, such as adenoviruses, may play an important role
during other seasons because adenoviruses circulate all
year-round in Taiwan. We proposed that it was not the same
infectious etiology, but rather heterogeneous infectious
agents in different areas and different seasons, which
trigger KD; there was no single pathogen reported to be
associated with KD worldwide. That is to say, different
pathogens might be responsible for KD in different countries
or different seasons. This may explain why no single path-
ogen was consistently found in cases with Kawasaki disease.
For example, Jordan-Villegas et al44 reported that 8.8% of
KD patients had documented respiratory viral infections
including rhinovirus, adenovirus, influenza, parainfluenza,
and respiratory syncytial virus. A recent article also re-
ported a case of KD associated with parainfluenza type
3 viral infection,45 and another article reported adenovirus
detection in some KD cases.46 However, Kim et al47 reported
that there was no significant association between the
presence of any of the 15 respiratory viruses and the inci-
dence of KD. New tests or techniques for specific microor-
ganisms may help us find the etiology of KD.48,49
In conclusion, we found that common respiratory vi-
ruses, such as enteroviruses, adenoviruses, rhinoviruses,
and coronaviruses, were associated with KD. Heteroge-
neous infectious etiologies may be responsible for KD in
different countries as well as during different seasons.
Appendix A. Supplementary data
Supplementary data related to this article can be found at
http://dx.doi.org/10.1016/j.jfma.2013.12.008.References
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